Biome Australia Ltd (AU:BIO) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Biome Australia Ltd has successfully identified and validated its new probiotic strain, Lactobacillus plantarum BMB18, marking a significant milestone in its intellectual property ownership and product development efforts. The strain, now registered with the German culture bank DSMZ, is expected to enhance Biome’s competitive edge and create new revenue opportunities. This development positions Biome for potential growth and innovation in the probiotic sector.
For further insights into AU:BIO stock, check out TipRanks’ Stock Analysis page.